Company Overview and News
One of the more popular strategies among investors today is to seek out “home runs.” These are lesser-known companies that have tremendous upside potential, but carry the risk of collapsing should business prospects go awry. While a balanced portfolio allows for some speculation, now is also a great time to consider S&P 500 stocks.
LMT HD EA FB UPS MA DRI FDX BBY HOG GT V AMZN CVX RTN ABBV HPQ MO
HP Inc. (HPQ - Free Report) recently announced a collaboration with Go 4-D to modernize orthotics. This alliance will enable Go 4-D to make cost-effective customized orthotics using HP Jet Fusion 3D printing systems. As a result of this tie-up, HP’s FitStation platform will be available across the North American medical market via Go 4-D. The FitStation platform offers a 3D foot scanning and gait analysis to better understand customer needs.
RDWR VSH HPQ FTNT
New Delhi: HP India on Monday introduced an affordable mini desktop to help students learn and collaborate in schools and educational institutions across the country. Starting at Rs 19,990, the HP 260 G3 desktop will enable schools and institutes to set up or upgrade computers in their science, technology, engineering and mathematics (STEM) labs at a minimal cost, the company said in a statement. “As technology becomes integral to businesses and consumers’ daily lives, students need to learn digital skills that equip them well for the future,” said Sumeer Chandra, Managing Director, HP India.
ZUG, Suisse - le 14 septembre 2018 - WISeKey International Holding Ltd (SIX : WIHN, OTCQX : WIKYY) (« WISeKey » ou la « Société »), une société suisse leader dans le domaine de la cybersécurité et de l'Internet des objets, a annoncé aujourd'hui ses résultats financiers audités pour le semestre clos le 30 juin 2018 (« S1 2018 »). Les revenus de WISeKey ont augmenté de 35 %, passant de 19,2 millions de dollars de revenus retraités au premier semestre 2017 à 25,9 millions de dollars, grâce à la hausse des revenus de l'activité Cybersécurité et IdO, et des semiconducteurs.
4704 TMICF JNPR CBLK TMICY HPQ
SAN FRANCISCO, Sept. 14, 2018 (GLOBE NEWSWIRE) -- HP Inc. today announced a strategic alliance with Go 4-D, a 3D printed medical orthotics industry visionary, to modernize the process used to create custom orthotics.
HP Inc. (HPQ - Free Report) is bolstering its competitive position in the 3-D printing market through continued innovation. The company recently launched an advanced 3D printing technology — HP Metal Jet — that aids cost-effective high volume manufacturing of production-grade metal parts. The company also launched the Metal Jet Production Service that allows customers to quickly imitate new 3D part designs, produce the final parts and incorporate the HP Metal Jet into their future production plans.
VJET SSYS ADSK HPQ
Redwood City, Calif., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Talend (NASDAQ: TLND), a global leader in cloud integration solutions, today announced it will debut at the Strata Data Conference in New York City a new sandbox that brings sophisticated machine learning technologies to the hands of developers and data engineers so they can easily create smarter data pipelines. With the Talend Big Data and Machine Learning Sandbox, data engineers can start using a step-by-step “cookbook” that includes pre-built machine learning proofs of concept and leverages Apache Spark, Spark Machine Learning Library (MLlib) and Spark Streaming in minutes without coding.
As value investors, we are always on the lookout for bargains - stocks or bonds that are trading at prices below our estimate of Fair Market Value (FMV). Both research and common sense dictate that the greater the discrepancy between price and FMV, the better it provides a higher possible margin of safety and implied upside. However, securities are often detached from their FMVs because the business is suffering, leaving investors to figure out whether the issues at hand will be minor and temporary or debilitating and permanent.
NPSNY SIEGY KGI.DB NXPI HUSKF MTLHY HPE DLTR HSE TJX MTLHF SWK 4188 BIDU ORCL KL BUD KGI KGI.DB.A WDO ASR TAP BABA 0700 AHBIF HPQ WDOFF DMLRY QCOM
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to HPQ / HP Inc. on message board site Silicon Investor.
|Hewlett-Packard (HPQ)||Hewlett-Packard (HPQ)||Hewlett-Packard (HPQ)||HWP -- Hewlett Packard||HWP -- Hewlett Packard||HWP -- Hewlett Packard|
as of ET